Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 242500
Key Takeaways
Risk factor
High price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E.
Data is available to registered users only
Target Price
The average target price of 298380.KQ is 127137 and suggests 47% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation
Data is available to registered users only
Buy
Sell